{"id":9051,"date":"2026-10-26T03:07:25","date_gmt":"2026-10-26T00:07:25","guid":{"rendered":"https:\/\/ulubeydental.com\/kimler-implant-yaptirabilir\/"},"modified":"2026-10-26T03:07:25","modified_gmt":"2026-10-26T00:07:25","slug":"kimler-implant-yaptirabilir","status":"publish","type":"post","link":"https:\/\/ulubeydental.com\/tr\/kimler-implant-yaptirabilir\/","title":{"rendered":"Kimler \u0130mplant Yapt\u0131rabilir? Sigara, Diyabet, Ya\u015f ve Kemik Kayb\u0131"},"content":{"rendered":"\n<style>\n  .ub-clinical-post {\n    font-family: -apple-system, BlinkMacSystemFont, \"Segoe UI\", Roboto, \"Helvetica Neue\", Arial, sans-serif;\n    color: #1e293b;\n    line-height: 1.85;\n    font-size: 17px;\n    max-width: 940px;\n    margin: 0 auto;\n    padding: 10px 0;\n  }\n  .ub-clinical-post p {\n    margin-bottom: 1.6rem;\n    color: #334155;\n  }\n  .ub-clinical-post h2 {\n    color: #0f172a;\n    font-size: 1.8rem;\n    font-weight: 700;\n    margin-top: 3.2rem;\n    margin-bottom: 1.25rem;\n    line-height: 1.3;\n    border-bottom: 2px solid #e2e8f0;\n    padding-bottom: 0.6rem;\n    scroll-margin-top: 80px;\n  }\n  .ub-clinical-post h3 {\n    color: #0369a1;\n    font-size: 1.35rem;\n    font-weight: 600;\n    margin-top: 2.2rem;\n    margin-bottom: 0.9rem;\n    scroll-margin-top: 80px;\n  }\n  \n  \/* BYLINE & EEAT CARD *\/\n  .ub-byline-card {\n    background: #f8fafc;\n    border: 1px solid #cbd5e1;\n    border-left: 5px solid #0284c7;\n    border-radius: 8px;\n    padding: 20px 24px;\n    margin-bottom: 2rem;\n    font-size: 0.93rem;\n  }\n  .ub-badge {\n    display: inline-block;\n    background: #e0f2fe;\n    color: #0284c7;\n    font-weight: 700;\n    font-size: 0.75rem;\n    padding: 3px 12px;\n    border-radius: 9999px;\n    margin-right: 8px;\n    text-transform: uppercase;\n    letter-spacing: 0.05em;\n  }\n  .ub-badge-gold {\n    background: #fef3c7;\n    color: #b45309;\n  }\n\n  \/* FAST-EXTRACTION AI \/ CLINICAL SUMMARY BOX *\/\n  .ub-ai-summary-box {\n    background: #f0fdf4;\n    border: 2px solid #86efac;\n    border-radius: 10px;\n    padding: 24px 26px;\n    margin: 2.2rem 0;\n    box-shadow: 0 4px 6px -1px rgba(0, 0, 0, 0.05);\n  }\n  .ub-ai-summary-header {\n    display: flex;\n    align-items: center;\n    gap: 10px;\n    font-size: 1.15rem;\n    font-weight: 700;\n    color: #166534;\n    margin-bottom: 12px;\n    text-transform: uppercase;\n    letter-spacing: 0.03em;\n  }\n  .ub-ai-summary-grid {\n    display: grid;\n    grid-template-columns: repeat(auto-fit, minmax(260px, 1fr));\n    gap: 12px 20px;\n    margin-top: 14px;\n    font-size: 0.92rem;\n    color: #14532d;\n  }\n  .ub-ai-summary-item {\n    background: #ffffff;\n    border: 1px solid #bbf7d0;\n    padding: 10px 14px;\n    border-radius: 6px;\n  }\n  .ub-ai-summary-item strong {\n    color: #0f172a;\n    display: block;\n    margin-bottom: 2px;\n  }\n\n  \/* TABLE OF CONTENTS *\/\n  .ub-toc-box {\n    background: #ffffff;\n    border: 1px solid #e2e8f0;\n    border-radius: 10px;\n    padding: 22px 26px;\n    margin: 2rem 0;\n    box-shadow: 0 2px 4px rgba(0,0,0,0.02);\n  }\n  .ub-toc-title {\n    font-size: 1.1rem;\n    font-weight: 700;\n    color: #0f172a;\n    margin-bottom: 12px;\n    display: flex;\n    align-items: center;\n    gap: 8px;\n  }\n  .ub-toc-list {\n    list-style: none;\n    padding: 0;\n    margin: 0;\n    display: grid;\n    grid-template-columns: repeat(auto-fit, minmax(340px, 1fr));\n    gap: 8px 16px;\n  }\n  .ub-toc-list li a {\n    color: #0284c7;\n    text-decoration: none;\n    font-size: 0.92rem;\n    font-weight: 500;\n    display: inline-flex;\n    align-items: center;\n    gap: 6px;\n  }\n  .ub-toc-list li a:hover {\n    color: #0369a1;\n    text-decoration: underline;\n  }\n\n  \/* MEDIA CONTAINER *\/\n  .ub-media-card {\n    background: #f8fafc;\n    border: 1px solid #e2e8f0;\n    border-radius: 12px;\n    padding: 16px;\n    margin: 2.5rem 0;\n    text-align: center;\n  }\n  .ub-media-img {\n    max-width: 100%;\n    height: auto;\n    border-radius: 8px;\n    box-shadow: 0 4px 6px -1px rgba(0,0,0,0.05);\n  }\n  .ub-media-caption {\n    font-size: 0.88rem;\n    color: #64748b;\n    margin-top: 10px;\n    line-height: 1.5;\n  }\n  .ud-diagram {\n    margin: 2.5rem auto;\n    text-align: center;\n  }\n  .ud-diagram img {\n    display: block;\n    margin: 0 auto;\n    border-radius: 8px;\n    box-shadow: 0 4px 6px -1px rgba(0,0,0,0.05);\n  }\n  .ud-diagram figcaption {\n    font-size: 0.88rem;\n    color: #64748b;\n    margin-top: 10px;\n    line-height: 1.5;\n  }\n\n  \/* BENCHMARK METRIC CARDS *\/\n  .ub-metric-grid {\n    display: grid;\n    grid-template-columns: repeat(auto-fit, minmax(240px, 1fr));\n    gap: 16px;\n    margin: 2.5rem 0;\n  }\n  .ub-metric-card {\n    background: #ffffff;\n    border: 1px solid #e2e8f0;\n    border-top: 4px solid #0284c7;\n    border-radius: 8px;\n    padding: 20px 22px;\n    box-shadow: 0 2px 4px rgba(0,0,0,0.03);\n  }\n  .ub-metric-val {\n    font-size: 2rem;\n    font-weight: 800;\n    color: #0284c7;\n    line-height: 1.1;\n    margin-bottom: 6px;\n  }\n  .ub-metric-label {\n    font-weight: 700;\n    color: #0f172a;\n    font-size: 0.98rem;\n    margin-bottom: 6px;\n  }\n  .ub-metric-desc {\n    font-size: 0.86rem;\n    color: #64748b;\n    line-height: 1.5;\n  }\n\n  \/* CALLOUT BOXES *\/\n  .ub-callout-box {\n    background: #f8fafc;\n    border: 1px solid #e2e8f0;\n    border-left: 4px solid #0284c7;\n    border-radius: 8px;\n    padding: 22px 24px;\n    margin: 2rem 0;\n  }\n  .ub-callout-box.alert {\n    background: #fef2f2;\n    border-color: #fecaca;\n    border-left-color: #dc2626;\n  }\n  .ub-callout-title {\n    font-weight: 700;\n    font-size: 1.1rem;\n    margin-bottom: 0.6rem;\n    display: flex;\n    align-items: center;\n    gap: 8px;\n  }\n  .ub-callout-box .ub-callout-title { color: #0369a1; }\n  .ub-callout-box.alert .ub-callout-title { color: #991b1b; }\n\n  \/* COMPARISON TABLES *\/\n  .ub-table-wrapper {\n    overflow-x: auto;\n    margin: 2.5rem 0;\n    border: 1px solid #e2e8f0;\n    border-radius: 8px;\n  }\n  .ub-table {\n    width: 100%;\n    border-collapse: collapse;\n    font-size: 0.93rem;\n    text-align: left;\n    background: #ffffff;\n  }\n  .ub-table th {\n    background: #0f172a;\n    color: #ffffff;\n    padding: 14px 18px;\n    font-weight: 600;\n  }\n  .ub-table td {\n    padding: 14px 18px;\n    border-bottom: 1px solid #f1f5f9;\n    color: #334155;\n    vertical-align: top;\n  }\n  .ub-table tr:last-child td { border-bottom: none; }\n  .ub-table tr:nth-child(even) td { background: #f8fafc; }\n  .ub-highlight { font-weight: 700; color: #0f172a; }\n\n  \/* CONVERSION \/ CTA CARDS *\/\n  .ub-cta-card {\n    background: linear-gradient(135deg, #0a192f 0%, #0f2b48 100%);\n    color: #ffffff;\n    border-radius: 12px;\n    padding: 34px 36px;\n    margin: 3.5rem 0;\n    box-shadow: 0 10px 25px -5px rgba(10, 25, 47, 0.3);\n    text-align: center;\n  }\n  .ub-cta-title {\n    color: #ffffff;\n    font-size: 1.65rem;\n    font-weight: 800;\n    margin-bottom: 12px;\n  }\n  .ub-cta-desc {\n    color: #cbd5e1;\n    font-size: 1.05rem;\n    max-width: 750px;\n    margin: 0 auto 24px auto;\n    line-height: 1.6;\n  }\n  .ub-cta-actions {\n    display: flex;\n    justify-content: center;\n    gap: 16px;\n    flex-wrap: wrap;\n  }\n  .ub-btn-whatsapp {\n    background-color: #25d366;\n    color: #ffffff !important;\n    font-weight: 700;\n    font-size: 1.05rem;\n    padding: 14px 28px;\n    border-radius: 8px;\n    text-decoration: none;\n    display: inline-flex;\n    align-items: center;\n    gap: 10px;\n    transition: all 0.2s ease;\n  }\n  .ub-btn-whatsapp:hover {\n    background-color: #1ebc57;\n    transform: translateY(-2px);\n  }\n  .ub-btn-secondary {\n    background-color: rgba(255,255,255,0.1);\n    color: #ffffff !important;\n    border: 1px solid rgba(255,255,255,0.25);\n    font-weight: 600;\n    font-size: 1.05rem;\n    padding: 14px 26px;\n    border-radius: 8px;\n    text-decoration: none;\n    display: inline-flex;\n    align-items: center;\n    gap: 8px;\n    transition: all 0.2s ease;\n  }\n  .ub-btn-secondary:hover {\n    background-color: rgba(255,255,255,0.2);\n  }\n\n  \/* PROTOCOL STEPS *\/\n  .ub-protocol-steps {\n    list-style: none;\n    padding: 0;\n    counter-reset: step-counter;\n    margin: 2rem 0;\n  }\n  .ub-protocol-steps li {\n    position: relative;\n    padding-left: 58px;\n    margin-bottom: 1.8rem;\n  }\n  .ub-protocol-steps li::before {\n    content: counter(step-counter);\n    counter-increment: step-counter;\n    position: absolute;\n    left: 0;\n    top: 2px;\n    width: 42px;\n    height: 42px;\n    background: #0284c7;\n    color: #ffffff;\n    font-weight: 800;\n    border-radius: 50%;\n    display: flex;\n    align-items: center;\n    justify-content: center;\n    font-size: 1.1rem;\n    box-shadow: 0 2px 4px rgba(2, 132, 199, 0.3);\n  }\n  .ub-protocol-steps h4 {\n    margin: 0 0 6px 0;\n    font-size: 1.15rem;\n    color: #0f172a;\n  }\n\n  \/* FAQS *\/\n  .ub-faq-item {\n    border: 1px solid #e2e8f0;\n    border-radius: 8px;\n    padding: 20px 24px;\n    margin-bottom: 14px;\n    background: #ffffff;\n  }\n  .ub-faq-q {\n    font-weight: 700;\n    color: #0f172a;\n    font-size: 1.08rem;\n    margin-bottom: 8px;\n  }\n  .ub-faq-a {\n    color: #475569;\n    font-size: 0.95rem;\n    line-height: 1.75;\n    margin: 0;\n  }\n\n  \/* REFERENCES *\/\n  .ub-references {\n    background: #f8fafc;\n    border: 1px solid #e2e8f0;\n    border-radius: 8px;\n    padding: 24px 28px;\n    margin-top: 3.5rem;\n    font-size: 0.86rem;\n    color: #64748b;\n  }\n  .ub-references h4 {\n    color: #1e293b;\n    margin: 0 0 14px 0;\n    font-size: 0.95rem;\n    text-transform: uppercase;\n    letter-spacing: 0.05em;\n  }\n  .ub-references ol { margin: 0; padding-left: 20px; }\n  .ub-references li { margin-bottom: 10px; }\n  .ub-references strong { color: #334155; }\n\n  \/* LINKS *\/\n  .ub-internal-link {\n    color: #0284c7;\n    font-weight: 600;\n    text-decoration: underline;\n  }\n  .ub-internal-link:hover { color: #0369a1; }\n  .ub-external-link {\n    color: #475569;\n    text-decoration: underline;\n    font-size: 0.9em;\n  }\n\n  \/* ADDITIONS (CU drafts 2026-10-25) *\/\n  .ub-table caption { caption-side: top; text-align: left; font-weight: 700; color: #0f172a; padding: 12px 18px; font-size: 0.95rem; background: #f8fafc; }\n  .ub-table-note { font-size: 0.84rem; color: #64748b; margin: -1.6rem 0 2rem 0; }\n  .ub-quick-answer { font-size: 1.02rem; color: #14532d; margin: 0 0 6px 0; }\n  @media (max-width: 600px) {\n    .ub-clinical-post { font-size: 16px; }\n    .ub-clinical-post h2 { font-size: 1.45rem; }\n    .ub-toc-list { grid-template-columns: 1fr; }\n    .ub-cta-card { padding: 26px 18px; }\n    .ub-table th, .ub-table td { padding: 10px 12px; }\n  }\n\n  .ub-emergency { border:2px solid #dc2626; background:#fef2f2; border-radius:10px; padding:14px 18px; margin:0 0 1.6rem 0; color:#7f1d1d; }\n<\/style>\n\n<div class=\"ub-clinical-post\">\n\n  <!-- BYLINE. Yaln\u0131z yazar sat\u0131r\u0131; t\u0131bbi i\u00e7erik kontrol\u00fc sat\u0131r\u0131 YOK (rulebook \u00a71.2: REVIEW-LOG.csv'de tarihli sat\u0131r olmadan eklenmez). -->\n  <div class=\"ub-byline-card\">\n    <div>\n      <span class=\"ub-badge\">Di\u015f implantlar\u0131<\/span>\n      <span class=\"ub-badge ub-badge-gold\">\u0130mplanta uygunluk<\/span>\n    <\/div>\n    <div style=\"margin-top: 12px; line-height: 1.7;\">\n      <strong>Yazar:<\/strong> <a href=\"https:\/\/ulubeydental.com\/tr\/dis-hekimlerimiz\/\" class=\"ub-internal-link\">Di\u015f Hekimi Ali Cem Ulubey<\/a> \u00b7 Ulubey Dental Clinic, Antalya<br>\n      <strong>Son g\u00fcncelleme:<\/strong> 26.10.2026<br>\n      <strong>\u0130\u00e7erik edit\u00f6r\u00fc:<\/strong> Dt. Ali Cem Ulubey \u00b7 <a href=\"mailto:info@ulubeydental.com\">info@ulubeydental.com<\/a>\n    <\/div>\n  <\/div>\n  <p style=\"font-size:0.92rem;color:#64748b;\">Bu sayfa genel bilgilendirmedir; muayenenin yerini tutmaz.<\/p>\n\n  <!-- KISA CEVAP -->\n  <div class=\"ub-ai-summary-box\">\n    <div class=\"ub-ai-summary-header\">K\u0131sa cevap<\/div>\n    <p class=\"ub-quick-answer\">Di\u015fini kaybetmi\u015f sa\u011fl\u0131kl\u0131 yeti\u015fkinlerin \u00e7o\u011fu, ileri ya\u015ftakiler de dahil, di\u015f implant\u0131 yapt\u0131rabilir: bir sistematik derleme ya\u015fl\u0131 hastalarda implant sa\u011fkal\u0131m\u0131n\u0131 \u00e7ok y\u00fcksek bulmu\u015ftur<sup><a href=\"#kaynak-6\">[6]<\/a><\/sup>. Ya\u015ftan daha \u00f6nemli olan, risk etkenlerinin kontrol alt\u0131nda olmas\u0131d\u0131r. Sigara implant kayb\u0131n\u0131 kabaca iki kat\u0131na \u00e7\u0131kar\u0131r<sup><a href=\"#kaynak-1\">[1]<\/a><\/sup>, kontrols\u00fcz diyabet iyile\u015fmeyi bozar<sup><a href=\"#kaynak-4\">[4]<\/a><\/sup>, ge\u00e7irilmi\u015f periodontitis ise peri-implantitis riskini art\u0131r\u0131r<sup><a href=\"#kaynak-5\">[5]<\/a><\/sup>. Antalya Muratpa\u015fa&#8217;daki klini\u011fimizde her implant hastas\u0131ndan \u00f6nce HbA1c dahil kan tahlilleri isteriz; HbA1c %7,0&#8217;\u0131n \u00fczerindeyse implant yapmay\u0131z ve damardan (IV) bisfosfonat tedavisinden sonra 5 y\u0131la kadar a\u011f\u0131z i\u00e7i cerrahi yapmay\u0131z.<\/p>\n    <div class=\"ub-ai-summary-grid\">\n      <div class=\"ub-ai-summary-item\"><strong>Sigara<\/strong><span>\u0130mplant kayb\u0131 sigara i\u00e7enlerde %6,35, i\u00e7meyenlerde %3,18 (107 \u00e7al\u0131\u015fma)<sup><a href=\"#kaynak-1\">[1]<\/a><\/sup>.<\/span><\/div>\n      <div class=\"ub-ai-summary-item\"><strong>Diyabet<\/strong><span>HbA1c&#8217;nin %6,8&#8217;in alt\u0131nda olmas\u0131n\u0131 tercih ederiz; implant cerrahisi i\u00e7in asla %7,0&#8217;\u0131n \u00fczerinde de\u011fil.<\/span><\/div>\n      <div class=\"ub-ai-summary-item\"><strong>Ya\u015f<\/strong><span>75 ya\u015f ve \u00fczeri hastalar\u0131 inceleyen bir derlemede (60 \u00e7al\u0131\u015fma) 1 y\u0131l sonra toplu implant sa\u011fkal\u0131m\u0131 %97,3<sup><a href=\"#kaynak-6\">[6]<\/a><\/sup>.<\/span><\/div>\n      <div class=\"ub-ai-summary-item\"><strong>Di\u015f eti hastal\u0131\u011f\u0131<\/strong><span>Ge\u00e7irilmi\u015f periodontitis, peri-implantitis i\u00e7in g\u00fc\u00e7l\u00fc bir risk etkenidir<sup><a href=\"#kaynak-5\">[5]<\/a><\/sup>.<\/span><\/div>\n      <div class=\"ub-ai-summary-item\"><strong>Damardan bisfosfonat<\/strong><span>Damardan bisfosfonat tedavisinden sonra 5 y\u0131la kadar a\u011f\u0131z i\u00e7i cerrahi yok (klini\u011fimizin kural\u0131).<\/span><\/div>\n      <div class=\"ub-ai-summary-item\"><strong>Kemik kayb\u0131<\/strong><span>\u00c7o\u011fu zaman kemik tozu (greft) veya sin\u00fcs lifting ile \u00e7\u00f6z\u00fclebilir; iyile\u015fme bu durumda yakla\u015f\u0131k 6 ay s\u00fcrer.<\/span><\/div>\n    <\/div>\n  <\/div>\n\n  <!-- \u0130\u00c7\u0130NDEK\u0130LER -->\n  <div class=\"ub-toc-box\">\n    <div class=\"ub-toc-title\">Bu rehberde<\/div>\n    <ul class=\"ub-toc-list\">\n      <li><a href=\"#uygunluk-listesi\">1. Kimler implant yapt\u0131rabilir? Uygunluk listesi<\/a><\/li>\n      <li><a href=\"#sigara\">2. Sigara i\u00e7enler implant yapt\u0131rabilir mi?<\/a><\/li>\n      <li><a href=\"#diyabet\">3. \u015eeker hastalar\u0131 implant yapt\u0131rabilir mi? HbA1c kurallar\u0131m\u0131z<\/a><\/li>\n      <li><a href=\"#dis-eti-hastaligi\">4. Di\u015f eti hastal\u0131\u011f\u0131 ve implant<\/a><\/li>\n      <li><a href=\"#kemik-kaybi\">5. Kemik yetersiz mi? Kemik tozu, sin\u00fcs lifting ve di\u011fer se\u00e7enekler<\/a><\/li>\n      <li><a href=\"#yas\">6. \u0130mplant i\u00e7in ya\u015f s\u0131n\u0131r\u0131 var m\u0131?<\/a><\/li>\n      <li><a href=\"#ilaclar-ve-hastaliklar\">7. \u0130mplant\u0131 etkileyen ila\u00e7lar ve hastal\u0131klar<\/a><\/li>\n      <li><a href=\"#implant-uygun-olmadiginda\">8. \u0130mplant ne zaman do\u011fru se\u00e7enek de\u011fildir?<\/a><\/li>\n      <li><a href=\"#uygunlugu-nasil-degerlendiriyoruz\">9. Ulubey Dental Clinic&#8217;te uygunlu\u011fu nas\u0131l de\u011ferlendiriyoruz?<\/a><\/li>\n      <li><a href=\"#sss\">10. S\u0131k sorulan sorular<\/a><\/li>\n      <li><a href=\"#kaynaklar\">11. Kaynaklar<\/a><\/li>\n    <\/ul>\n  <\/div>\n\n  <h2 id=\"uygunluk-listesi\">Kimler implant yapt\u0131rabilir? Uygunluk listesi<\/h2>\n  <p>Bir di\u015f implant\u0131 \u00fc\u00e7 \u015feye ihtiya\u00e7 duyar: onu tutacak kadar sa\u011fl\u0131kl\u0131 kemik, \u00e7evresinde sa\u011fl\u0131kl\u0131 di\u015f etleri ve iyi iyile\u015fen bir v\u00fccut. Bu sayfadaki sorular\u0131n \u00e7o\u011fu bu \u00fc\u00e7\u00fcnden birine dayan\u0131r. \u0130mplant\u0131 tamamen engelleyen durum \u00e7ok azd\u0131r; bir\u00e7o\u011fu yaln\u0131zca \u00f6nce bir \u015feyin tedavi edilmesi veya kontrol alt\u0131na al\u0131nmas\u0131 gerekti\u011fi anlam\u0131na gelir.<\/p>\n  <!-- IMAGE SLOT (designer, T-748 TR version): kimler-implant-yaptirabilir-uygunluk-listesi.svg \u00b7 alt=\"\u0130mplant uygunluk listesi: yeterli sa\u011fl\u0131kl\u0131 kemik, sa\u011fl\u0131kl\u0131 di\u015f etleri ve iyi iyile\u015fen bir v\u00fccut; ba\u015fl\u0131ca risk etkenleri\" \u00b7 caption: Temsili \u00e7izim, hasta g\u00f6r\u00fcnt\u00fcs\u00fc de\u011fildir. Basitle\u015ftirilmi\u015f liste; karar\u0131 muayene, r\u00f6ntgenler ve kan tahlilleri verir. \u00c7al\u0131\u015fma verileri bu sayfada kaynaklar\u0131yla verilmi\u015ftir. Her cerrahi veya giri\u015fimsel i\u015flemde sonu\u00e7lar ki\u015fiden ki\u015fiye de\u011fi\u015fiklik g\u00f6sterebilir. \u0130\u015flem \u00f6ncesinde hekiminizden detayl\u0131 g\u00f6r\u00fc\u015f alman\u0131z \u00f6nerilir. \u00b7 note: G\u00d6RSEL YUVASI: EN who-can-get-dental-implants-candidacy-checklist.svg metinleri \u0130ngilizce \u2192 designer TR etiketli kopya \u00fcretir. \u00b7 enable after upload: <figure class=\"wp-block-image size-full ud-diagram\"><img src=\"SRC\" width=\"640\" height=\"826\" loading=\"lazy\" decoding=\"async\" alt=\"\u0130mplant uygunluk listesi: yeterli sa\u011fl\u0131kl\u0131 kemik, sa\u011fl\u0131kl\u0131 di\u015f etleri ve iyi iyile\u015fen bir v\u00fccut; ba\u015fl\u0131ca risk etkenleri\" style=\"width:100%;max-width:640px;height:auto\"><figcaption class=\"wp-element-caption\">Temsili \u00e7izim, hasta g\u00f6r\u00fcnt\u00fcs\u00fc de\u011fildir. Basitle\u015ftirilmi\u015f liste; karar\u0131 muayene, r\u00f6ntgenler ve kan tahlilleri verir. \u00c7al\u0131\u015fma verileri bu sayfada kaynaklar\u0131yla verilmi\u015ftir. Her cerrahi veya giri\u015fimsel i\u015flemde sonu\u00e7lar ki\u015fiden ki\u015fiye de\u011fi\u015fiklik g\u00f6sterebilir. \u0130\u015flem \u00f6ncesinde hekiminizden detayl\u0131 g\u00f6r\u00fc\u015f alman\u0131z \u00f6nerilir.<\/figcaption><\/figure> -->\n  <div class=\"ub-table-wrapper\" id=\"implant-uygunluk-tablosu\">\n    <table class=\"ub-table\">\n      <caption>Di\u015f implant\u0131na uygunluk listesi: ne \u00f6nemlidir, ne yap\u0131yoruz?<\/caption>\n      <thead>\n        <tr><th scope=\"col\">Etken<\/th><th scope=\"col\">Neden \u00f6nemli?<\/th><th scope=\"col\">Ne yap\u0131yoruz?<\/th><\/tr>\n      <\/thead>\n      <tbody>\n        <tr><th scope=\"row\" class=\"ub-highlight\">Sigara<\/th><td>\u0130mplant kayb\u0131n\u0131 kabaca iki kat\u0131na \u00e7\u0131kar\u0131r; daha fazla kemik kayb\u0131 ve enfeksiyon<sup><a href=\"#kaynak-1\">[1]<\/a><\/sup><sup><a href=\"#kaynak-2\">[2]<\/a><\/sup><\/td><td>M\u00fcmk\u00fcn oldu\u011funca erken, ideal olarak en az 4 hafta \u00f6nce b\u0131rak\u0131n; b\u0131rakam\u0131yorsan\u0131z g\u00fcnde en fazla 6\u20138; sonras\u0131nda en az 1 hafta hi\u00e7<\/td><\/tr>\n        <tr><th scope=\"row\" class=\"ub-highlight\">Diyabet<\/th><td>K\u00f6t\u00fc kontrol osseointegrasyonu bozar, kay\u0131p ve peri-implantitis riskini art\u0131r\u0131r<sup><a href=\"#kaynak-4\">[4]<\/a><\/sup><\/td><td>Cerrahiden \u00f6nce HbA1c; tercihen %6,8&#8217;in alt\u0131nda; asla %7,0&#8217;\u0131n \u00fczerinde de\u011fil<\/td><\/tr>\n        <tr><th scope=\"row\" class=\"ub-highlight\">Di\u015f eti hastal\u0131\u011f\u0131<\/th><td>Ge\u00e7irilmi\u015f periodontitis peri-implantitis riskini art\u0131r\u0131r<sup><a href=\"#kaynak-5\">[5]<\/a><\/sup><\/td><td>Di\u015f eti hastal\u0131\u011f\u0131 implanttan \u00f6nce tedavi edilir ve kontrol alt\u0131na al\u0131n\u0131r<\/td><\/tr>\n        <tr><th scope=\"row\" class=\"ub-highlight\">Kemik kayb\u0131<\/th><td>\u0130mplant\u0131n sabit durmas\u0131 i\u00e7in kemik hacmi gerekir<\/td><td>Kemik tozu, blok greft, kapal\u0131 veya a\u00e7\u0131k sin\u00fcs lifting; nadiren mini implant<\/td><\/tr>\n        <tr><th scope=\"row\" class=\"ub-highlight\">Ya\u015f<\/th><td>\u0130leri ya\u015f tek ba\u015f\u0131na bir engel de\u011fildir<sup><a href=\"#kaynak-6\">[6]<\/a><\/sup><\/td><td>Ya\u015f\u0131n kendisini de\u011fil, genel sa\u011fl\u0131\u011f\u0131 ve ila\u00e7lar\u0131 de\u011ferlendiririz<\/td><\/tr>\n        <tr><th scope=\"row\" class=\"ub-highlight\">Kemik ila\u00e7lar\u0131 (bisfosfonat, denosumab)<\/th><td>\u0130laca ba\u011fl\u0131 \u00e7ene kemi\u011fi nekrozu (MRONJ) riski<sup><a href=\"#kaynak-7\">[7]<\/a><\/sup><sup><a href=\"#kaynak-8\">[8]<\/a><\/sup><\/td><td>Kendi hekiminize y\u00f6nlendirme; damardan bisfosfonattan sonra 5 y\u0131la kadar a\u011f\u0131z i\u00e7i cerrahi yok<\/td><\/tr>\n        <tr><th scope=\"row\" class=\"ub-highlight\">Kan suland\u0131r\u0131c\u0131lar<\/th><td>Cerrahi s\u0131ras\u0131nda ve sonras\u0131nda daha fazla kanama<sup><a href=\"#kaynak-9\">[9]<\/a><\/sup><\/td><td>\u0130lac\u0131 yazan hekime dan\u0131\u015f\u0131r, onun onay\u0131ndan sonra hareket ederiz<\/td><\/tr>\n        <tr><th scope=\"row\" class=\"ub-highlight\">Hamilelik<\/th><td>Planl\u0131 (elektif) cerrahi ertelenir<\/td><td>\u0130mplant do\u011fumdan sonra<\/td><\/tr>\n      <\/tbody>\n    <\/table>\n  <\/div>\n  <p class=\"ub-table-note\">Kaynaklar h\u00fccrelerde belirtilmi\u015ftir; &#8220;Ne yap\u0131yoruz?&#8221; s\u00fctunu Ulubey Dental Clinic&#8217;in protokol\u00fcd\u00fcr. Bu tabloyu bu sayfaya ba\u011flant\u0131 vererek al\u0131nt\u0131layabilirsiniz.<\/p>\n\n  <h2 id=\"sigara\">Sigara i\u00e7enler implant yapt\u0131rabilir mi?<\/h2>\n  <p>Sigara implant\u0131 otomatik olarak engellemez, ancak en belirgin risklerden biridir. 107 \u00e7al\u0131\u015fmay\u0131 i\u00e7eren bir meta-analiz, implant kayb\u0131n\u0131 sigara i\u00e7enlere yerle\u015ftirilen implantlar\u0131n %6,35&#8217;inde, i\u00e7meyenlerde %3,18&#8217;inde bulmu\u015f; sigara i\u00e7enlerde ameliyat sonras\u0131 enfeksiyon ve implant \u00e7evresinde kemik kayb\u0131 da daha fazla g\u00f6r\u00fclm\u00fc\u015ft\u00fcr<sup><a href=\"#kaynak-1\">[1]<\/a><\/sup>. 44 \u00e7al\u0131\u015fmay\u0131 i\u00e7eren 2026 tarihli bir sistematik derleme de sigara i\u00e7enlerde daha d\u00fc\u015f\u00fck implant sa\u011fkal\u0131m\u0131 ve 0,64 mm daha fazla kemik kayb\u0131 bulmu\u015ftur. Derleme, sigaran\u0131n kesin bir engel olmad\u0131\u011f\u0131, ancak sigaray\u0131 b\u0131rakma deste\u011finin her zaman tedavi plan\u0131n\u0131n bir par\u00e7as\u0131 olmas\u0131 gerekti\u011fi sonucuna varm\u0131\u015ft\u0131r<sup><a href=\"#kaynak-2\">[2]<\/a><\/sup>.<\/p>\n  <ul>\n    <li><strong>Cerrahiden \u00f6nce:<\/strong> m\u00fcmk\u00fcn oldu\u011funca erken, ideal olarak en az 4 hafta \u00f6nce b\u0131rak\u0131n. Genel cerrahide ameliyattan en az 3\u20134 hafta \u00f6nce b\u0131rakmak yara iyile\u015fmesi komplikasyonlar\u0131n\u0131 azaltm\u0131\u015ft\u0131r<sup><a href=\"#kaynak-3\">[3]<\/a><\/sup>.<\/li>\n    <li><strong>B\u0131rakam\u0131yorsan\u0131z:<\/strong> olabildi\u011fince azalt\u0131n; g\u00fcnde en fazla 6\u20138 sigara isteriz. Bu bir ara \u00e7\u00f6z\u00fcmd\u00fcr, g\u00fcvenli bir s\u0131n\u0131r de\u011fildir.<\/li>\n    <li><strong>Cerrahiden sonra:<\/strong> yara kapanana kadar, en az 1 hafta sigara i\u00e7meyin; implant ve kemik tozu uygulamalar\u0131nda daha uzun s\u00fcre daha iyidir.<\/li>\n  <\/ul>\n  <p>2026 tarihli derleme, dumans\u0131z \u00fcr\u00fcnlerin riskini de\u011ferlendirmek i\u00e7in verilerin \u00e7ok az oldu\u011funu bulmu\u015ftur<sup><a href=\"#kaynak-2\">[2]<\/a><\/sup>. Ameliyattan sonra sizi nelerin bekledi\u011fi <a href=\"https:\/\/ulubeydental.com\/tr\/implant-sonrasi-bakim\/\" class=\"ub-internal-link\">implant sonras\u0131 bak\u0131m<\/a> rehberimizde anlat\u0131lmaktad\u0131r.<\/p>\n\n  <h2 id=\"diyabet\">\u015eeker hastalar\u0131 implant yapt\u0131rabilir mi? HbA1c kurallar\u0131m\u0131z<\/h2>\n  <p>Diyabeti olan ki\u015filer, kan \u015fekeri iyi kontrol alt\u0131nda oldu\u011fu s\u00fcrece implant yapt\u0131rabilir. 22 klinik \u00e7al\u0131\u015fmay\u0131 inceleyen bir sistematik derleme, k\u00f6t\u00fc kontroll\u00fc diyabeti olan hastalarda osseointegrasyonun bozuldu\u011fu, peri-implantitis riskinin ve implant kay\u0131plar\u0131n\u0131n artt\u0131\u011f\u0131; iyi kontroll\u00fc diyabette ise implant i\u015flemlerinin g\u00fcvenli ve \u00f6ng\u00f6r\u00fclebilir oldu\u011fu, komplikasyon oran\u0131n\u0131n sa\u011fl\u0131kl\u0131 hastalar\u0131nkine benzer oldu\u011fu sonucuna varm\u0131\u015ft\u0131r<sup><a href=\"#kaynak-4\">[4]<\/a><\/sup>.<\/p>\n  <p>Kontrol\u00fc g\u00f6steren test HbA1c&#8217;dir. Kurallar\u0131m\u0131z kat\u0131d\u0131r:<\/p>\n  <ul>\n    <li><strong>Tercih edilen:<\/strong> HbA1c&#8217;nin <strong>%6,8&#8217;in alt\u0131nda<\/strong> olmas\u0131 (yakla\u015f\u0131k 51 mmol\/mol).<\/li>\n    <li><strong>Daha y\u00fcksekse:<\/strong> diyabetli hastay\u0131, HbA1c yakla\u015f\u0131k <strong>%6,4&#8217;e<\/strong> (yakla\u015f\u0131k 46 mmol\/mol) d\u00fc\u015f\u00fcr\u00fcld\u00fckten ve <strong>3 ay<\/strong> izlendikten sonra, hekiminizle birlikte ve tedavi s\u00fcresi i\u00e7in belirlenen kurallarla tedavi ederiz.<\/li>\n    <li><strong>Asla %7,0&#8217;\u0131n \u00fczerinde de\u011fil<\/strong> (yakla\u015f\u0131k 53 mmol\/mol): bu de\u011ferin \u00fczerinde implant yapmay\u0131z.<\/li>\n  <\/ul>\n  <!-- IMAGE SLOT (designer, T-748 TR version): kimler-implant-yaptirabilir-hba1c-esikleri.svg \u00b7 alt=\"\u0130mplant cerrahisi i\u00e7in HbA1c \u00f6l\u00e7e\u011fi: tercihen %6,8'in alt\u0131, y\u00fcksekse yakla\u015f\u0131k %6,4'e d\u00fc\u015f\u00fcr\u00fcl\u00fcr, asla %7,0'\u0131n \u00fczeri de\u011fil\" \u00b7 caption: Temsili \u00e7izim. \u0130mplant cerrahisi i\u00e7in HbA1c kurallar\u0131m\u0131z. HbA1c her implant hastas\u0131ndan \u00f6nce \u00f6l\u00e7\u00fcl\u00fcr; karar hekiminizle birlikte verilir. \u00b7 note: G\u00d6RSEL YUVASI: EN who-can-get-dental-implants-hba1c-thresholds.svg metinleri \u0130ngilizce \u2192 designer TR etiketli kopya \u00fcretir. \u00b7 enable after upload: <figure class=\"wp-block-image size-full ud-diagram\"><img src=\"SRC\" width=\"640\" height=\"600\" loading=\"lazy\" decoding=\"async\" alt=\"\u0130mplant cerrahisi i\u00e7in HbA1c \u00f6l\u00e7e\u011fi: tercihen %6,8'in alt\u0131, y\u00fcksekse yakla\u015f\u0131k %6,4'e d\u00fc\u015f\u00fcr\u00fcl\u00fcr, asla %7,0'\u0131n \u00fczeri de\u011fil\" style=\"width:100%;max-width:640px;height:auto\"><figcaption class=\"wp-element-caption\">Temsili \u00e7izim. \u0130mplant cerrahisi i\u00e7in HbA1c kurallar\u0131m\u0131z. HbA1c her implant hastas\u0131ndan \u00f6nce \u00f6l\u00e7\u00fcl\u00fcr; karar hekiminizle birlikte verilir.<\/figcaption><\/figure> -->\n  <p>HbA1c&#8217;yi yaln\u0131zca diyabeti oldu\u011funu bilenlerde de\u011fil, her implant hastas\u0131nda \u00f6l\u00e7eriz. Bu rutin tahliller \u00e7o\u011fu zaman hastan\u0131n bilmedi\u011fi y\u00fcksek bir HbA1c de\u011ferini ortaya \u00e7\u0131karm\u0131\u015ft\u0131r. Diyabetiniz oldu\u011funu biliyorsan\u0131z, r\u00f6ntgeninizi g\u00f6nderirken son HbA1c sonucunuzu ve ila\u00e7 listenizi de ekleyin. Diyabet ile di\u015f eti sa\u011fl\u0131\u011f\u0131 aras\u0131ndaki ba\u011flant\u0131, sistemik hastal\u0131klar ve a\u011f\u0131z sa\u011fl\u0131\u011f\u0131 rehberimizde anlat\u0131lmaktad\u0131r.<!-- link \u2192 https:\/\/ulubeydental.com\/tr\/sistemik-hastaliklar-ve-agiz-sagligi\/ (N3-06 TR) yay\u0131na girince --><\/p>\n\n  <h2 id=\"dis-eti-hastaligi\">Di\u015f eti hastal\u0131\u011f\u0131 ve implant<\/h2>\n  <p>Di\u015f eti hastal\u0131\u011f\u0131 ile implantlar yak\u0131ndan ili\u015fkilidir. Peri-implantitis \u00fczerine 2017 D\u00fcnya \u00c7al\u0131\u015ftay\u0131 derlemesi, ge\u00e7irilmi\u015f kronik periodontitisin, yetersiz plak kontrol\u00fcn\u00fcn ve implant tedavisinden sonra d\u00fczenli bak\u0131m yap\u0131lmamas\u0131n\u0131n, implantlar\u0131 etkileyebilen iltihap ve kemik kayb\u0131 olan peri-implantitis riskini art\u0131rd\u0131\u011f\u0131na dair g\u00fc\u00e7l\u00fc kan\u0131t bulmu\u015ftur<sup><a href=\"#kaynak-5\">[5]<\/a><\/sup>.<\/p>\n  <p>Bu, di\u015flerini di\u015f eti hastal\u0131\u011f\u0131 nedeniyle kaybedenlerin implant yapt\u0131ramayaca\u011f\u0131 anlam\u0131na gelmez. Di\u015f eti hastal\u0131\u011f\u0131n\u0131n \u00f6nce tedavi edilmesi ve kontrol alt\u0131na al\u0131nmas\u0131, evde temizlik ve d\u00fczenli kontrollerin de ilk g\u00fcnden plan\u0131n par\u00e7as\u0131 olmas\u0131 gerekti\u011fi anlam\u0131na gelir. \u0130mplant cerrahisinden \u00f6nce hangi tedavinin gerekti\u011fine di\u015f hekimi muayenede karar verir. \u0130mplant iyile\u015ftikten sonra a\u011f\u0131z du\u015fu, ara y\u00fcz f\u0131r\u00e7as\u0131 veya di\u015f ipi ve di\u015f f\u0131r\u00e7an\u0131z\u0131 kullanman\u0131z\u0131 \u00f6nerir, nas\u0131l kullanaca\u011f\u0131n\u0131z\u0131 kendi implantlar\u0131n\u0131z \u00fczerinde g\u00f6steririz.<\/p>\n  <p>Sundu\u011fumuz temizlik <a href=\"https:\/\/ulubeydental.com\/tr\/dis-tasi-temizligi\/\" class=\"ub-internal-link\">di\u015f ta\u015f\u0131 temizli\u011fi<\/a> sayfam\u0131zda anlat\u0131lmaktad\u0131r.<\/p>\n\n  <h2 id=\"kemik-kaybi\">Kemik yetersiz mi? Kemik tozu, sin\u00fcs lifting ve di\u011fer se\u00e7enekler<\/h2>\n  <p>Bir di\u015f kaybedildikten sonra o b\u00f6lgedeki \u00e7ene kemi\u011fi zamanla k\u00fc\u00e7\u00fcl\u00fcr. Kemik kayb\u0131, insanlara &#8220;implant yap\u0131lamaz&#8221; denmesinin en s\u0131k nedenlerinden biridir; ancak \u00e7o\u011fu durumda bunun da bir \u00e7\u00f6z\u00fcm\u00fc vard\u0131r.<\/p>\n  <ul>\n    <li><strong>Kemik tozu (greft):<\/strong> kemi\u011fin ince oldu\u011fu yere kemik tozu eklenir; gerekti\u011finde blok greft de yap\u0131l\u0131r. Domuz kaynakl\u0131 olmayan greft ve membran se\u00e7enekleri iste\u011finiz \u00fczerine kullan\u0131labilir; malzemeyi di\u015f hekiminiz se\u00e7er.<!-- link \u2192 https:\/\/ulubeydental.com\/tr\/kemik-tozu-greft\/ (U-1.9 TR) yay\u0131na girince --><\/li>\n    <li><strong>Soket koruma:<\/strong> bir di\u015f \u00e7ekilip implant daha sonraya planlan\u0131yorsa, ayn\u0131 seansta yuvaya greft yerle\u015ftirilebilir.<\/li>\n    <li><strong>Sin\u00fcs lifting:<\/strong> \u00fcst \u00e7enenin arka b\u00f6lgesinde kapal\u0131 veya a\u00e7\u0131k sin\u00fcs lifting, implant i\u00e7in yer a\u00e7ar.<\/li>\n    <li><strong>Mini implantlar:<\/strong> nadiren, yaln\u0131zca gerekti\u011finde kullan\u0131l\u0131r; \u00f6rne\u011fin ileri cerrahiden ka\u00e7\u0131n\u0131lmas\u0131 gereken ve kemi\u011fi ince olan ya\u015fl\u0131 hastalarda.<\/li>\n  <\/ul>\n  <p>Kemik tozu s\u00fcreyi uzat\u0131r: kal\u0131c\u0131 kaplamadan \u00f6nceki iyile\u015fme standart bir implantta yakla\u015f\u0131k 3 ay, kemik tozu veya a\u00e7\u0131k sin\u00fcs lifting ile ortalama yakla\u015f\u0131k 6 ay s\u00fcrer. Kemik tozuna ihtiyac\u0131n\u0131z olup olmad\u0131\u011f\u0131na r\u00f6ntgenler ve gerekti\u011finde 3D tomografi (CBCT) ile karar verilir.<\/p>\n\n  <h2 id=\"yas\">\u0130mplant i\u00e7in ya\u015f s\u0131n\u0131r\u0131 var m\u0131?<\/h2>\n  <p>\u0130mplant i\u00e7in bir \u00fcst ya\u015f s\u0131n\u0131r\u0131 yoktur. Ya\u015fl\u0131 hastalarda implantlar\u0131 inceleyen 60 \u00e7al\u0131\u015fmal\u0131k bir sistematik derleme, 75 ya\u015f ve \u00fczeri hastalarda y\u00fckleme sonras\u0131 toplu implant sa\u011fkal\u0131m\u0131n\u0131 1 y\u0131lda %97,3 (5 y\u0131lda %96,1) bulmu\u015f ve ya\u015fl\u0131larda implant \u00fcst\u00fc protezlerin implant sa\u011fkal\u0131m\u0131 \u00e7ok y\u00fcksek, \u00f6ng\u00f6r\u00fclebilir bir tedavi oldu\u011fu sonucuna varm\u0131\u015ft\u0131r<sup><a href=\"#kaynak-6\">[6]<\/a><\/sup>. Ayn\u0131 derleme, kalp-damar hastal\u0131\u011f\u0131 olanlarda implant sa\u011fkal\u0131m\u0131n\u0131n benzer veya daha y\u00fcksek olabilece\u011fini, tip 2 diyabet veya Parkinson hastal\u0131\u011f\u0131 olanlarda da y\u00fcksek oldu\u011funu bulmu\u015ftur<sup><a href=\"#kaynak-6\">[6]<\/a><\/sup>.<\/p>\n  <p>Ya\u015fla birlikte de\u011fi\u015fen \u00e7o\u011fu zaman kemi\u011fin iyile\u015fme yetene\u011fi de\u011fil, ila\u00e7 listesi ve genel sa\u011fl\u0131kt\u0131r. Bu y\u00fczden t\u00fcm sa\u011fl\u0131k ge\u00e7mi\u015fine bakar\u0131z. Gen\u00e7lerde ise implant ancak di\u015f hekimi \u00e7ene geli\u015fiminin tamamland\u0131\u011f\u0131n\u0131 kontrol ettikten sonra yap\u0131l\u0131r<sup><a href=\"#kaynak-11\">[11]<\/a><\/sup>.<\/p>\n\n  <h2 id=\"ilaclar-ve-hastaliklar\">\u0130mplant\u0131 etkileyen ila\u00e7lar ve hastal\u0131klar<\/h2>\n  <h3>Kemik g\u00fc\u00e7lendirici ila\u00e7lar (bisfosfonat, denosumab)<\/h3>\n  <p>Bu ila\u00e7lar kemik erimesini (osteoporoz) ve baz\u0131 kanserleri tedavi eder. Nadir de olsa, \u00e7ene kemi\u011finin a\u00e7\u0131\u011fa \u00e7\u0131kt\u0131\u011f\u0131 ilaca ba\u011fl\u0131 \u00e7ene kemi\u011fi nekrozu (MRONJ) riski ta\u015f\u0131rlar. SDCEP, osteoporoz i\u00e7in bu riski 1.000&#8217;de 1 ile 10.000&#8217;de 1 aras\u0131nda verir; di\u015f \u00e7ekimi veya implant gibi kemi\u011fi etkileyen tedavilerde risk artar, ancak yine de d\u00fc\u015f\u00fck kabul edilir<sup><a href=\"#kaynak-7\">[7]<\/a><\/sup>. Kanser i\u00e7in kullan\u0131lan kemik y\u0131k\u0131m\u0131n\u0131 \u00f6nleyici ila\u00e7larda risk genellikle 20&#8217;de 1&#8217;den azd\u0131r<sup><a href=\"#kaynak-8\">[8]<\/a><\/sup>. Ya\u015fl\u0131 hastalar derlemesi de osteoporoz i\u00e7in d\u00fc\u015f\u00fck doz tedavide implant sa\u011fkal\u0131m\u0131n\u0131 y\u00fcksek, kemik metastazlar\u0131 i\u00e7in y\u00fcksek doz tedavide ise implant cerrahisi sonras\u0131 komplikasyon riskini y\u00fcksek bulmu\u015ftur<sup><a href=\"#kaynak-6\">[6]<\/a><\/sup>.<\/p>\n  <p><strong>Kural\u0131m\u0131z:<\/strong> bisfosfonat kullanan hastalar\u0131 \u00f6nce kendi hekimlerine y\u00f6nlendiririz. Bisfosfonat i\u011fneyle (damardan) verildiyse <strong>5 y\u0131la kadar a\u011f\u0131z i\u00e7i cerrahi yapmay\u0131z<\/strong>. Kemik ilac\u0131n\u0131z\u0131 kendi kendinize b\u0131rakmay\u0131n; SDCEP, yarar\u0131 \u00e7o\u011fu zaman risklerinden \u00e7ok daha fazla oldu\u011fu i\u00e7in ilaca devam edilmesini \u00f6nerir<sup><a href=\"#kaynak-7\">[7]<\/a><\/sup>.<\/p>\n  <h3>Kan suland\u0131r\u0131c\u0131lar<\/h3>\n  <p>Kan suland\u0131r\u0131c\u0131 (antikoag\u00fclan) ve kan p\u0131ht\u0131la\u015fmas\u0131n\u0131 \u00f6nleyici (antiplatelet) ila\u00e7lar tehlikeli p\u0131ht\u0131lar\u0131 \u00f6nlemeye yard\u0131mc\u0131 olur, ancak daha kolay kanaman\u0131za yol a\u00e7ar<sup><a href=\"#kaynak-9\">[9]<\/a><\/sup>. Hekiminiz veya di\u015f hekiminiz s\u00f6ylemedik\u00e7e bu ila\u00e7lar\u0131 di\u015f tedavisi i\u00e7in de\u011fi\u015ftirmeyin<sup><a href=\"#kaynak-9\">[9]<\/a><\/sup>. Cerrahiden \u00f6nce ilac\u0131 yazan hekime dan\u0131\u015f\u0131r ve onun onay\u0131ndan sonra hareket ederiz; hekim cerrahiye izin verir veya gerekirse ilac\u0131 ayarlar.<\/p>\n  <h3>Kalp hastal\u0131klar\u0131<\/h3>\n  <p>Amerikan Kalp Derne\u011fi, baz\u0131 di\u015f i\u015flemlerinden \u00f6nce antibiyotik korumas\u0131n\u0131 yaln\u0131zca enfektif endokardit a\u00e7\u0131s\u0131ndan en y\u00fcksek risk ta\u015f\u0131yan hastalara \u00f6nerir<sup><a href=\"#kaynak-10\">[10]<\/a><\/sup>. Bu hastalardan biriyseniz bize s\u00f6yleyin: koruyucu antibiyotik almas\u0131 gereken hastalara i\u015flemden \u00f6nce antibiyotik verilir.<\/p>\n  <h3>Kanser tedavisi ve radyoterapi<\/h3>\n  <p>Ya\u015fl\u0131 hastalar derlemesi, kanser hastalar\u0131nda implant sa\u011fkal\u0131m\u0131n\u0131n, esas olarak radyoterapi nedeniyle olumsuz etkilendi\u011fini bulmu\u015ftur<sup><a href=\"#kaynak-6\">[6]<\/a><\/sup>. Ba\u015f veya boyun b\u00f6lgesine radyoterapi ald\u0131ysan\u0131z ya da kanser ilac\u0131 kullan\u0131yorsan\u0131z bize s\u00f6yleyin: implant cerrahisinin uygun olup olmad\u0131\u011f\u0131na di\u015f hekimi sizi tedavi eden hekimle birlikte karar verir; implant do\u011fru se\u00e7enek olmayabilir.<\/p>\n  <h3>Hamilelik<\/h3>\n  <p>Hamilelikte yaln\u0131zca hekiminizin onaylad\u0131\u011f\u0131 acil i\u015fleri, ikinci \u00fc\u00e7 ayl\u0131k d\u00f6nemde yapar\u0131z. \u0130mplant dahil kal\u0131c\u0131 tedaviler do\u011fumdan sonraya ertelenir.<\/p>\n\n  <h2 id=\"implant-uygun-olmadiginda\">\u0130mplant ne zaman do\u011fru se\u00e7enek de\u011fildir?<\/h2>\n  <p>D\u00fcr\u00fcst bir de\u011ferlendirme bazen &#8220;\u015fimdi de\u011fil&#8221; ya da &#8220;implant de\u011fil&#8221; diye biter. Klini\u011fimizde implant \u015fu durumlarda do\u011fru se\u00e7enek <strong>de\u011fildir<\/strong> veya hen\u00fcz de\u011fildir:<\/p>\n  <ul>\n    <li>HbA1c %7,0&#8217;\u0131n \u00fczerindeyse: \u00f6nce diyabetin kontrol\u00fc gelir;<\/li>\n    <li>son 5 y\u0131l i\u00e7inde damardan bisfosfonat ald\u0131ysan\u0131z;<\/li>\n    <li>hamileyseniz: implant do\u011fumdan sonray\u0131 bekler;<\/li>\n    <li>aktif di\u015f eti hastal\u0131\u011f\u0131 hen\u00fcz tedavi edilmediyse;<\/li>\n    <li>hekiminiz, \u00f6rne\u011fin kan suland\u0131r\u0131c\u0131 veya kalp tedavisi nedeniyle cerrahiyi onaylam\u0131yorsa;<\/li>\n    <li>ba\u015f-boyun radyoterapisi veya kanser tedavisi, sizi tedavi eden hekimle birlikte verilen kararla, riski \u00e7ok y\u00fcksek k\u0131l\u0131yorsa;<\/li>\n    <li>\u00e7ok sigara i\u00e7iyor ve azaltam\u0131yorsan\u0131z: implant yine m\u00fcmk\u00fcnd\u00fcr, ancak risk daha y\u00fcksektir<sup><a href=\"#kaynak-1\">[1]<\/a><\/sup><sup><a href=\"#kaynak-2\">[2]<\/a><\/sup>; karar vermeden \u00f6nce bunu size anlat\u0131r\u0131z.<\/li>\n  <\/ul>\n  <p>Di\u015fleri tamamlaman\u0131n ba\u015fka yollar\u0131 da vard\u0131r. <a href=\"https:\/\/ulubeydental.com\/tr\/implant-mi-kopru-mu\/\" class=\"ub-internal-link\">\u0130mplant m\u0131 k\u00f6pr\u00fc m\u00fc<\/a> ve <a href=\"https:\/\/ulubeydental.com\/tr\/implant-mi-protez-mi\/\" class=\"ub-internal-link\">implant m\u0131 protez mi<\/a> rehberlerimiz bunlar\u0131 kar\u015f\u0131la\u015ft\u0131r\u0131r. Halk aras\u0131nda \u201cMaryland k\u00f6pr\u00fc\u201d denen rezin ba\u011fl\u0131 (adeziv) k\u00f6pr\u00fcy\u00fc rutin bir se\u00e7enek olarak de\u011fil, yaln\u0131zca ger\u00e7ekten gerekti\u011finde kullan\u0131yoruz; yap\u0131\u015ft\u0131rman\u0131n \u00e7\u00f6z\u00fclme riski nedeniyle klini\u011fe yak\u0131n oturan hastalar i\u00e7in uygundur.<\/p>\n\n  <h2 id=\"uygunlugu-nasil-degerlendiriyoruz\">Ulubey Dental Clinic&#8217;te uygunlu\u011fu nas\u0131l de\u011ferlendiriyoruz?<\/h2>\n  <ul>\n    <li><strong>\u0130ki hekim:<\/strong> Di\u015f Hekimi Ali Cem Ulubey ve Di\u015f Hekimi Surur Ulubey hastalar\u0131n\u0131 bizzat muayene eder; tedavinizi iki hekim bizzat planlar, yapar ve takip eder; tedavi a\u015famalar\u0131 aras\u0131nda vakan\u0131z ba\u015fka bir hekime devredilmez.<\/li>\n    <li><strong>R\u00f6ntgenler:<\/strong> her hastam\u0131za panoramik r\u00f6ntgen; vaka kemi\u011fin \u00fc\u00e7 boyutlu g\u00f6r\u00fcnt\u00fcs\u00fcn\u00fc gerektirdi\u011finde di\u015f hekimlerimizin de\u011ferlendirdi\u011fi 3D tomografi (CBCT).<\/li>\n    <li><strong>Her implant hastas\u0131ndan \u00f6nce rutin kan tahlilleri:<\/strong> tam kan say\u0131m\u0131, biyokimya, HbA1c, a\u00e7l\u0131k kan \u015fekeri, D vitamini ve kalsiyum.<\/li>\n    <li><strong>Sa\u011fl\u0131k ge\u00e7mi\u015fi:<\/strong> ila\u00e7lar, alerjiler, kalp hastal\u0131klar\u0131, kemik ila\u00e7lar\u0131 ve kan suland\u0131r\u0131c\u0131lar; gerekti\u011finde hekiminizle ileti\u015fime ge\u00e7eriz.<\/li>\n    <li><strong>Yaz\u0131l\u0131 plan:<\/strong> r\u00f6ntgeninizi ve foto\u011fraflar\u0131n\u0131z\u0131 WhatsApp&#8217;tan g\u00f6nderebilir ya da muayeneye gelebilirsiniz; kesin plan muayeneden sonra netle\u015fir. \u00dccret, muayene ve r\u00f6ntgen sonras\u0131, tedaviden \u00f6nce yaz\u0131l\u0131 olarak bildirilir.<\/li>\n  <\/ul>\n  <p>\u0130mplant se\u00e7enekleri ve s\u00fcre\u00e7 i\u00e7in <a href=\"https:\/\/ulubeydental.com\/tr\/antalya-implant\/\" class=\"ub-internal-link\">Antalya di\u015f implant\u0131<\/a> sayfam\u0131za ve <a href=\"https:\/\/ulubeydental.com\/tr\/implant-yaptirmadan-once\/\" class=\"ub-internal-link\">implant yapt\u0131rmadan \u00f6nce bilmeniz gerekenler<\/a> yaz\u0131m\u0131za bakabilirsiniz.<\/p>\n\n  <h2 id=\"sss\">S\u0131k sorulan sorular<\/h2>\n  <div class=\"ub-faq-item\">\n    <h3 class=\"ub-faq-q\">Sigara i\u00e7iyorum, implant yapt\u0131rabilir miyim?<\/h3>\n    <p class=\"ub-faq-a\">Genellikle evet, ancak risk daha y\u00fcksektir: b\u00fcy\u00fck bir derleme implant kayb\u0131n\u0131 sigara i\u00e7enlerde implantlar\u0131n %6,35&#8217;inde, i\u00e7meyenlerde %3,18&#8217;inde bulmu\u015ftur. M\u00fcmk\u00fcn oldu\u011funca erken, ideal olarak cerrahiden en az 4 hafta \u00f6nce b\u0131rak\u0131n. B\u0131rakam\u0131yorsan\u0131z olabildi\u011fince azalt\u0131n; g\u00fcnde en fazla 6\u20138 sigara isteriz ve cerrahiden sonra en az 1 hafta hi\u00e7 i\u00e7ilmemelidir.<\/p>\n  <\/div>\n  <div class=\"ub-faq-item\">\n    <h3 class=\"ub-faq-q\">\u015eeker hastalar\u0131 implant yapt\u0131rabilir mi?<\/h3>\n    <p class=\"ub-faq-a\">Evet, diyabet iyi kontrol alt\u0131ndaysa. Derlemeler, iyi kontroll\u00fc diyabette implant sonu\u00e7lar\u0131n\u0131n sa\u011fl\u0131kl\u0131 hastalar\u0131nkine benzer oldu\u011funu bulur. HbA1c&#8217;nin %6,8&#8217;in alt\u0131nda olmas\u0131n\u0131 tercih ederiz. Daha y\u00fcksekse, yakla\u015f\u0131k %6,4&#8217;e d\u00fc\u015f\u00fcr\u00fcl\u00fcp 3 ay izlendikten sonra tedavi ederiz. HbA1c %7,0&#8217;\u0131n \u00fczerindeyken asla implant yapmay\u0131z.<\/p>\n  <\/div>\n  <div class=\"ub-faq-item\">\n    <h3 class=\"ub-faq-q\">\u0130mplant i\u00e7in ya\u015f\u0131m ge\u00e7mi\u015f olabilir mi?<\/h3>\n    <p class=\"ub-faq-a\">Bir \u00fcst ya\u015f s\u0131n\u0131r\u0131 yoktur. 60 \u00e7al\u0131\u015fmay\u0131 i\u00e7eren bir sistematik derleme, 75 ya\u015f ve \u00fczeri hastalarda 1 y\u0131l sonra toplu implant sa\u011fkal\u0131m\u0131n\u0131 %97,3 bulmu\u015f ve ya\u015fl\u0131larda implant\u0131 \u00f6ng\u00f6r\u00fclebilir bir tedavi olarak tan\u0131mlam\u0131\u015ft\u0131r. \u00d6nemli olan genel sa\u011fl\u0131k ve ila\u00e7 listesidir; \u00f6rne\u011fin kemik g\u00fc\u00e7lendirici ila\u00e7lar veya kan suland\u0131r\u0131c\u0131lar, bunlar\u0131 planlamadan \u00f6nce inceleriz.<\/p>\n  <\/div>\n  <div class=\"ub-faq-item\">\n    <h3 class=\"ub-faq-q\">Di\u015f eti hastal\u0131\u011f\u0131 ge\u00e7irdim, implant yapt\u0131rabilir miyim?<\/h3>\n    <p class=\"ub-faq-a\">Di\u015f eti hastal\u0131\u011f\u0131 tedavi edilip kontrol alt\u0131na al\u0131nd\u0131ktan sonra \u00e7o\u011fu zaman evet. Ge\u00e7irilmi\u015f periodontitis peri-implantitis i\u00e7in g\u00fc\u00e7l\u00fc bir risk etkenidir; bu y\u00fczden evde iyi temizlik ve d\u00fczenli kontroller plan\u0131n par\u00e7as\u0131d\u0131r. \u0130mplant cerrahisinden \u00f6nce hangi di\u015f eti tedavisinin gerekti\u011fine di\u015f hekimi muayenede karar verir.<\/p>\n  <\/div>\n  <div class=\"ub-faq-item\">\n    <h3 class=\"ub-faq-q\">Bisfosfonat kullan\u0131yorum, implant yapt\u0131rabilir miyim?<\/h3>\n    <p class=\"ub-faq-a\">\u0130lac\u0131 nas\u0131l ve neden kulland\u0131\u011f\u0131n\u0131za ba\u011fl\u0131d\u0131r. Bisfosfonat kullanan hastalar\u0131 \u00f6nce kendi hekimlerine y\u00f6nlendiririz. Bisfosfonat i\u011fneyle (damardan) verildiyse 5 y\u0131la kadar a\u011f\u0131z i\u00e7i cerrahi yapmay\u0131z. Kemik ilac\u0131n\u0131z\u0131 kendi kendinize b\u0131rakmay\u0131n; t\u0131bbi yarar\u0131 \u00e7o\u011fu zaman \u00e7enedeki k\u00fc\u00e7\u00fck riskten daha a\u011f\u0131r basar.<\/p>\n  <\/div>\n  <div class=\"ub-faq-item\">\n    <h3 class=\"ub-faq-q\">\u0130mplant i\u00e7in kemi\u011fim yetersizse ne olur?<\/h3>\n    <p class=\"ub-faq-a\">Kemik kayb\u0131 \u00e7o\u011fu zaman kemik tozu, blok greft veya \u00fcst \u00e7enenin arka b\u00f6lgesinde kapal\u0131 ya da a\u00e7\u0131k sin\u00fcs lifting ile \u00e7\u00f6z\u00fclebilir. Kemi\u011fi ince olan se\u00e7ilmi\u015f ya\u015fl\u0131 hastalarda bazen mini implant kullan\u0131l\u0131r. Kemik tozu, kal\u0131c\u0131 kaplamadan \u00f6nceki iyile\u015fmeyi ortalama yakla\u015f\u0131k 6 aya uzat\u0131r. Neyin m\u00fcmk\u00fcn oldu\u011funu r\u00f6ntgenler ve gerekti\u011finde 3D tomografi (CBCT) g\u00f6sterir.<\/p>\n  <\/div>\n\n  <!-- CTA: acil durum blo\u011fundan ayr\u0131 (rulebook \u00a73.3). -->\n  <div class=\"ub-cta-card\">\n    <div class=\"ub-cta-title\">\u0130mplant\u0131n size uygun olup olmad\u0131\u011f\u0131n\u0131 \u00f6\u011frenin<\/div>\n    <div class=\"ub-cta-desc\">R\u00f6ntgeninizi, birka\u00e7 foto\u011fraf\u0131n\u0131z\u0131 ve ila\u00e7 listenizi WhatsApp&#8217;tan g\u00f6nderebilir ya da muayene i\u00e7in klini\u011fimize gelebilirsiniz. Mesajlar genellikle 4 saat i\u00e7inde yan\u0131tlan\u0131r. Kesin tan\u0131 ve tedavi plan\u0131 muayene ve r\u00f6ntgen sonras\u0131nda netle\u015fir.<br><small>\u00c7a\u011flayan Mh., Bar\u0131naklar Blv., \u00d6zen 2 Apt. No: 109A, Muratpa\u015fa\/Antalya (Lara b\u00f6lgesi) \u00b7 Otopark imk\u00e2n\u0131 mevcuttur. \u00b7 Pazartesi\u2013Cumartesi 09:00\u201319:00<\/small><\/div>\n    <div class=\"ub-cta-actions\">\n      <a href=\"https:\/\/wa.me\/905403240004?text=Merhaba%2C%20implanta%20uygun%20olup%20olmad%C4%B1%C4%9F%C4%B1m%C4%B1%20%C3%B6%C4%9Frenmek%20istiyorum.\" class=\"ub-btn-whatsapp\" target=\"_blank\" rel=\"noopener noreferrer\">WhatsApp&#8217;tan yaz\u0131n (+90 540 324 00 04)<\/a>\n      <a href=\"https:\/\/ulubeydental.com\/tr\/antalya-implant\/\" class=\"ub-btn-secondary\">Antalya di\u015f implant\u0131<\/a>\n    <\/div>\n  <\/div>\n\n  <div class=\"ub-references\" id=\"kaynaklar\">\n    <h4>Kaynaklar (\u0130ngilizce)<\/h4>\n    <ol>\n      <li id=\"kaynak-1\"><strong>Chrcanovic BR, Albrektsson T, Wennerberg A.<\/strong> Smoking and dental implants: a systematic review and meta-analysis. <em>J Dent<\/em>. 2015;43(5):487-498. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25778741\/\" class=\"ub-external-link\" target=\"_blank\" rel=\"noopener\">pubmed.ncbi.nlm.nih.gov\/25778741<\/a><\/li>\n      <li id=\"kaynak-2\"><strong>Calciolari E, Corbella S, Dourou M, Ercal P, Donos N.<\/strong> Tobacco smoking and smoke-free products as risk factors for dental implants: a systematic review. <em>Clin Oral Implants Res<\/em>. 2026;37(3):262-286. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/41776304\/\" class=\"ub-external-link\" target=\"_blank\" rel=\"noopener\">pubmed.ncbi.nlm.nih.gov\/41776304<\/a><\/li>\n      <li id=\"kaynak-3\"><strong>Wong J, Lam DP, Abrishami A, Chan MT, Chung F.<\/strong> Short-term preoperative smoking cessation and postoperative complications: a systematic review and meta-analysis. <em>Can J Anaesth<\/em>. 2012;59(3):268-279. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/22187226\/\" class=\"ub-external-link\" target=\"_blank\" rel=\"noopener\">pubmed.ncbi.nlm.nih.gov\/22187226<\/a><\/li>\n      <li id=\"kaynak-4\"><strong>Naujokat H, Kunzendorf B, Wiltfang J.<\/strong> Dental implants and diabetes mellitus: a systematic review. <em>Int J Implant Dent<\/em>. 2016;2(1):5. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27747697\/\" class=\"ub-external-link\" target=\"_blank\" rel=\"noopener\">pubmed.ncbi.nlm.nih.gov\/27747697<\/a><\/li>\n      <li id=\"kaynak-5\"><strong>Schwarz F, Derks J, Monje A, Wang HL.<\/strong> Peri-implantitis. <em>J Periodontol<\/em>. 2018;89 Suppl 1:S267-S290. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29926957\/\" class=\"ub-external-link\" target=\"_blank\" rel=\"noopener\">pubmed.ncbi.nlm.nih.gov\/29926957<\/a><\/li>\n      <li id=\"kaynak-6\"><strong>Schimmel M, Srinivasan M, McKenna G, M\u00fcller F.<\/strong> Effect of advanced age and\/or systemic medical conditions on dental implant survival: a systematic review and meta-analysis. <em>Clin Oral Implants Res<\/em>. 2018;29 Suppl 16:311-330. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30328186\/\" class=\"ub-external-link\" target=\"_blank\" rel=\"noopener\">pubmed.ncbi.nlm.nih.gov\/30328186<\/a><\/li>\n      <li id=\"kaynak-7\"><strong>SDCEP.<\/strong> Dental advice for patients prescribed anti-resorptive drugs for the treatment of osteoporosis or other non-malignant diseases of bone (hasta bro\u015f\u00fcr\u00fc; eri\u015fim 25 Ekim 2026). <a href=\"https:\/\/www.sdcep.org.uk\/media\/0fldawef\/sdcep-mronj-information-for-osteoporosis-patients.pdf\" class=\"ub-external-link\" target=\"_blank\" rel=\"noopener\">www.sdcep.org.uk\/media\/0fldawef\/sdcep-mronj-information-for-osteoporosis-patients.pdf<\/a><\/li>\n      <li id=\"kaynak-8\"><strong>SDCEP.<\/strong> MRONJ information for patients prescribed anti-resorptive or anti-angiogenic drugs for cancer (hasta bro\u015f\u00fcr\u00fc; eri\u015fim 25 Ekim 2026). <a href=\"https:\/\/www.sdcep.org.uk\/media\/bdwo1l44\/sdcep-mronj-information-for-cancer-patients.pdf\" class=\"ub-external-link\" target=\"_blank\" rel=\"noopener\">www.sdcep.org.uk\/media\/bdwo1l44\/sdcep-mronj-information-for-cancer-patients.pdf<\/a><\/li>\n      <li id=\"kaynak-9\"><strong>SDCEP.<\/strong> Anticoagulant or antiplatelet medication and your dental treatment: information for patients (2022; eri\u015fim 25 Ekim 2026). <a href=\"https:\/\/www.sdcep.org.uk\/media\/r3cjkyl5\/sdcep-anticoagulant-or-antiplatelet-medication-and-your-dental-treatment.pdf\" class=\"ub-external-link\" target=\"_blank\" rel=\"noopener\">www.sdcep.org.uk\/media\/r3cjkyl5\/sdcep-anticoagulant-or-antiplatelet-medication-and-your-dental-treatment.pdf<\/a><\/li>\n      <li id=\"kaynak-10\"><strong>Wilson WR, Gewitz M, Lockhart PB, et al.<\/strong> Prevention of viridans group streptococcal infective endocarditis: a scientific statement from the American Heart Association. <em>Circulation<\/em>. 2021;143(20):e963-e978. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33853363\/\" class=\"ub-external-link\" target=\"_blank\" rel=\"noopener\">pubmed.ncbi.nlm.nih.gov\/33853363<\/a><\/li>\n      <li id=\"kaynak-11\"><strong>Mankani N, Chowdhary R, Patil BA, Nagaraj E, Madalli P.<\/strong> Osseointegrated dental implants in growing children: a literature review. <em>J Oral Implantol<\/em>. 2014;40(5):627-631. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/22214484\/\" class=\"ub-external-link\" target=\"_blank\" rel=\"noopener\">pubmed.ncbi.nlm.nih.gov\/22214484<\/a><\/li>\n    <\/ol>\n    <p style=\"margin:12px 0 0 0;\">Bu yaz\u0131 genel hasta bilgilendirmesidir; klinik muayenenin yerini tutmaz. Her cerrahi veya giri\u015fimsel i\u015flemde sonu\u00e7lar ki\u015fiden ki\u015fiye de\u011fi\u015fiklik g\u00f6sterebilir. \u0130\u015flem \u00f6ncesinde hekiminizden detayl\u0131 g\u00f6r\u00fc\u015f alman\u0131z \u00f6nerilir.<\/p>\n  <\/div>\n\n<\/div>\n\n<script type=\"application\/ld+json\">\n{\n \"@context\": \"https:\/\/schema.org\",\n \"@graph\": [\n  {\n   \"@type\": \"MedicalWebPage\",\n   \"@id\": \"https:\/\/ulubeydental.com\/tr\/kimler-implant-yaptirabilir\/#webpage\",\n   \"url\": \"https:\/\/ulubeydental.com\/tr\/kimler-implant-yaptirabilir\/\",\n   \"name\": \"Kimler \u0130mplant Yapt\u0131rabilir? Sigara, \u015eeker Hastal\u0131\u011f\u0131, Ya\u015f ve Kemik\",\n   \"headline\": \"Kimler \u0130mplant Yapt\u0131rabilir? Sigara, \u015eeker Hastal\u0131\u011f\u0131, Ya\u015f ve Kemik\",\n   \"description\": \"Sigara i\u00e7enler, \u015feker hastalar\u0131 ve ileri ya\u015ftakiler implant yapt\u0131rabilir mi? HbA1c kurallar\u0131m\u0131z, kemik yetersizli\u011fi ve implant\u0131n uygun olmad\u0131\u011f\u0131 durumlar. Antalya Muratpa\u015fa.\",\n   \"inLanguage\": \"tr\",\n   \"isPartOf\": {\n    \"@id\": \"https:\/\/ulubeydental.com\/#website\"\n   },\n   \"author\": {\n    \"@id\": \"https:\/\/ulubeydental.com\/#dr-ali-cem-ulubey\"\n   },\n   \"publisher\": {\n    \"@id\": \"https:\/\/ulubeydental.com\/#organization\"\n   },\n   \"datePublished\": \"2026-10-26\",\n   \"dateModified\": \"2026-10-26\",\n   \"medicalAudience\": {\n    \"@type\": \"MedicalAudience\",\n    \"audienceType\": \"Patient\"\n   },\n   \"about\": {\n    \"@type\": \"MedicalProcedure\",\n    \"name\": \"Di\u015f implant\u0131\",\n    \"procedureType\": \"https:\/\/schema.org\/SurgicalProcedure\",\n    \"contraindication\": [\n     \"HbA1c %7,0'\u0131n \u00fczerinde (klinik kural\u0131)\",\n     \"Son 5 y\u0131l i\u00e7inde damardan bisfosfonat tedavisi (klinik kural\u0131)\",\n     \"Hamilelik (planl\u0131 tedavi ertelenir)\",\n     \"Tedavi edilmemi\u015f periodontitis\"\n    ],\n    \"preparation\": \"Sa\u011fl\u0131k ge\u00e7mi\u015fi, panoramik r\u00f6ntgen, gerekti\u011finde 3D tomografi (CBCT), HbA1c dahil rutin kan tahlilleri; kan suland\u0131r\u0131c\u0131lar ve kemik ila\u00e7lar\u0131 i\u00e7in hekim g\u00f6r\u00fc\u015f\u00fc.\"\n   },\n   \"citation\": [\n    \"https:\/\/pubmed.ncbi.nlm.nih.gov\/25778741\/\",\n    \"https:\/\/pubmed.ncbi.nlm.nih.gov\/41776304\/\",\n    \"https:\/\/pubmed.ncbi.nlm.nih.gov\/22187226\/\",\n    \"https:\/\/pubmed.ncbi.nlm.nih.gov\/27747697\/\",\n    \"https:\/\/pubmed.ncbi.nlm.nih.gov\/29926957\/\",\n    \"https:\/\/pubmed.ncbi.nlm.nih.gov\/30328186\/\",\n    \"https:\/\/www.sdcep.org.uk\/media\/0fldawef\/sdcep-mronj-information-for-osteoporosis-patients.pdf\",\n    \"https:\/\/www.sdcep.org.uk\/media\/bdwo1l44\/sdcep-mronj-information-for-cancer-patients.pdf\",\n    \"https:\/\/www.sdcep.org.uk\/media\/r3cjkyl5\/sdcep-anticoagulant-or-antiplatelet-medication-and-your-dental-treatment.pdf\",\n    \"https:\/\/pubmed.ncbi.nlm.nih.gov\/33853363\/\",\n    \"https:\/\/pubmed.ncbi.nlm.nih.gov\/22214484\/\"\n   ]\n  },\n  {\n   \"@type\": \"FAQPage\",\n   \"@id\": \"https:\/\/ulubeydental.com\/tr\/kimler-implant-yaptirabilir\/#sss\",\n   \"isPartOf\": {\n    \"@id\": \"https:\/\/ulubeydental.com\/tr\/kimler-implant-yaptirabilir\/#webpage\"\n   },\n   \"mainEntity\": [\n    {\n     \"@type\": \"Question\",\n     \"name\": \"Sigara i\u00e7iyorum, implant yapt\u0131rabilir miyim?\",\n     \"acceptedAnswer\": {\n      \"@type\": \"Answer\",\n      \"text\": \"Genellikle evet, ancak risk daha y\u00fcksektir: b\u00fcy\u00fck bir derleme implant kayb\u0131n\u0131 sigara i\u00e7enlerde implantlar\u0131n %6,35'inde, i\u00e7meyenlerde %3,18'inde bulmu\u015ftur. M\u00fcmk\u00fcn oldu\u011funca erken, ideal olarak cerrahiden en az 4 hafta \u00f6nce b\u0131rak\u0131n. B\u0131rakam\u0131yorsan\u0131z olabildi\u011fince azalt\u0131n; g\u00fcnde en fazla 6\u20138 sigara isteriz ve cerrahiden sonra en az 1 hafta hi\u00e7 i\u00e7ilmemelidir.\"\n     }\n    },\n    {\n     \"@type\": \"Question\",\n     \"name\": \"\u015eeker hastalar\u0131 implant yapt\u0131rabilir mi?\",\n     \"acceptedAnswer\": {\n      \"@type\": \"Answer\",\n      \"text\": \"Evet, diyabet iyi kontrol alt\u0131ndaysa. Derlemeler, iyi kontroll\u00fc diyabette implant sonu\u00e7lar\u0131n\u0131n sa\u011fl\u0131kl\u0131 hastalar\u0131nkine benzer oldu\u011funu bulur. HbA1c'nin %6,8'in alt\u0131nda olmas\u0131n\u0131 tercih ederiz. Daha y\u00fcksekse, yakla\u015f\u0131k %6,4'e d\u00fc\u015f\u00fcr\u00fcl\u00fcp 3 ay izlendikten sonra tedavi ederiz. HbA1c %7,0'\u0131n \u00fczerindeyken asla implant yapmay\u0131z.\"\n     }\n    },\n    {\n     \"@type\": \"Question\",\n     \"name\": \"\u0130mplant i\u00e7in ya\u015f\u0131m ge\u00e7mi\u015f olabilir mi?\",\n     \"acceptedAnswer\": {\n      \"@type\": \"Answer\",\n      \"text\": \"Bir \u00fcst ya\u015f s\u0131n\u0131r\u0131 yoktur. 60 \u00e7al\u0131\u015fmay\u0131 i\u00e7eren bir sistematik derleme, 75 ya\u015f ve \u00fczeri hastalarda 1 y\u0131l sonra toplu implant sa\u011fkal\u0131m\u0131n\u0131 %97,3 bulmu\u015f ve ya\u015fl\u0131larda implant\u0131 \u00f6ng\u00f6r\u00fclebilir bir tedavi olarak tan\u0131mlam\u0131\u015ft\u0131r. \u00d6nemli olan genel sa\u011fl\u0131k ve ila\u00e7 listesidir; \u00f6rne\u011fin kemik g\u00fc\u00e7lendirici ila\u00e7lar veya kan suland\u0131r\u0131c\u0131lar, bunlar\u0131 planlamadan \u00f6nce inceleriz.\"\n     }\n    },\n    {\n     \"@type\": \"Question\",\n     \"name\": \"Di\u015f eti hastal\u0131\u011f\u0131 ge\u00e7irdim, implant yapt\u0131rabilir miyim?\",\n     \"acceptedAnswer\": {\n      \"@type\": \"Answer\",\n      \"text\": \"Di\u015f eti hastal\u0131\u011f\u0131 tedavi edilip kontrol alt\u0131na al\u0131nd\u0131ktan sonra \u00e7o\u011fu zaman evet. Ge\u00e7irilmi\u015f periodontitis peri-implantitis i\u00e7in g\u00fc\u00e7l\u00fc bir risk etkenidir; bu y\u00fczden evde iyi temizlik ve d\u00fczenli kontroller plan\u0131n par\u00e7as\u0131d\u0131r. \u0130mplant cerrahisinden \u00f6nce hangi di\u015f eti tedavisinin gerekti\u011fine di\u015f hekimi muayenede karar verir.\"\n     }\n    },\n    {\n     \"@type\": \"Question\",\n     \"name\": \"Bisfosfonat kullan\u0131yorum, implant yapt\u0131rabilir miyim?\",\n     \"acceptedAnswer\": {\n      \"@type\": \"Answer\",\n      \"text\": \"\u0130lac\u0131 nas\u0131l ve neden kulland\u0131\u011f\u0131n\u0131za ba\u011fl\u0131d\u0131r. Bisfosfonat kullanan hastalar\u0131 \u00f6nce kendi hekimlerine y\u00f6nlendiririz. Bisfosfonat i\u011fneyle (damardan) verildiyse 5 y\u0131la kadar a\u011f\u0131z i\u00e7i cerrahi yapmay\u0131z. Kemik ilac\u0131n\u0131z\u0131 kendi kendinize b\u0131rakmay\u0131n; t\u0131bbi yarar\u0131 \u00e7o\u011fu zaman \u00e7enedeki k\u00fc\u00e7\u00fck riskten daha a\u011f\u0131r basar.\"\n     }\n    },\n    {\n     \"@type\": \"Question\",\n     \"name\": \"\u0130mplant i\u00e7in kemi\u011fim yetersizse ne olur?\",\n     \"acceptedAnswer\": {\n      \"@type\": \"Answer\",\n      \"text\": \"Kemik kayb\u0131 \u00e7o\u011fu zaman kemik tozu, blok greft veya \u00fcst \u00e7enenin arka b\u00f6lgesinde kapal\u0131 ya da a\u00e7\u0131k sin\u00fcs lifting ile \u00e7\u00f6z\u00fclebilir. Kemi\u011fi ince olan se\u00e7ilmi\u015f ya\u015fl\u0131 hastalarda bazen mini implant kullan\u0131l\u0131r. Kemik tozu, kal\u0131c\u0131 kaplamadan \u00f6nceki iyile\u015fmeyi ortalama yakla\u015f\u0131k 6 aya uzat\u0131r. Neyin m\u00fcmk\u00fcn oldu\u011funu r\u00f6ntgenler ve gerekti\u011finde 3D tomografi (CBCT) g\u00f6sterir.\"\n     }\n    }\n   ]\n  }\n ]\n}\n<\/script>\n\n","protected":false},"excerpt":{"rendered":"<p>Di\u015f implantlar\u0131 \u0130mplanta uygunluk Yazar: Di\u015f Hekimi Ali Cem Ulubey \u00b7 Ulubey Dental Clinic, Antalya Son g\u00fcncelleme: 26.10.2026 \u0130\u00e7erik edit\u00f6r\u00fc: Dt. Ali Cem Ulubey \u00b7 info@ulubeydental.com Bu sayfa genel bilgilendirmedir; muayenenin yerini tutmaz. K\u0131sa cevap Di\u015fini kaybetmi\u015f sa\u011fl\u0131kl\u0131 yeti\u015fkinlerin \u00e7o\u011fu, ileri ya\u015ftakiler de dahil, di\u015f implant\u0131 yapt\u0131rabilir: bir sistematik derleme ya\u015fl\u0131 hastalarda implant sa\u011fkal\u0131m\u0131n\u0131 \u00e7ok&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_kad_blocks_custom_css":"","_kad_blocks_head_custom_js":"","_kad_blocks_body_custom_js":"","_kad_blocks_footer_custom_js":"","_kadence_starter_templates_imported_post":false,"_kad_post_transparent":"","_kad_post_title":"","_kad_post_layout":"","_kad_post_sidebar_id":"","_kad_post_content_style":"","_kad_post_vertical_padding":"","_kad_post_feature":"","_kad_post_feature_position":"","_kad_post_header":false,"_kad_post_footer":false,"_kad_post_classname":"","_joinchat":[],"footnotes":""},"categories":[313],"tags":[],"class_list":["post-9051","post","type-post","status-publish","format-standard","hentry","category-dis-implanti"],"taxonomy_info":{"category":[{"value":313,"label":"Di\u015f \u0130mplant\u0131"}]},"featured_image_src_large":false,"author_info":{"display_name":"Dt. Ali Cem Ulubey","author_link":"https:\/\/ulubeydental.com\/tr\/author\/ali-cem\/"},"comment_info":0,"category_info":[{"term_id":313,"name":"Di\u015f \u0130mplant\u0131","slug":"dis-implanti","term_group":0,"term_taxonomy_id":313,"taxonomy":"category","description":"","parent":0,"count":9,"filter":"raw","cat_ID":313,"category_count":9,"category_description":"","cat_name":"Di\u015f \u0130mplant\u0131","category_nicename":"dis-implanti","category_parent":0}],"tag_info":false,"_links":{"self":[{"href":"https:\/\/ulubeydental.com\/tr\/wp-json\/wp\/v2\/posts\/9051","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ulubeydental.com\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ulubeydental.com\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ulubeydental.com\/tr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ulubeydental.com\/tr\/wp-json\/wp\/v2\/comments?post=9051"}],"version-history":[{"count":0,"href":"https:\/\/ulubeydental.com\/tr\/wp-json\/wp\/v2\/posts\/9051\/revisions"}],"wp:attachment":[{"href":"https:\/\/ulubeydental.com\/tr\/wp-json\/wp\/v2\/media?parent=9051"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ulubeydental.com\/tr\/wp-json\/wp\/v2\/categories?post=9051"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ulubeydental.com\/tr\/wp-json\/wp\/v2\/tags?post=9051"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}